Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970207_aadci_125.txtODS MEDICAL LESSONS LEARNED PERSONNEL CATEGORY PERSONNEL ISSUE NO. 15 Pyridostigmine Side Effects (SGHR ITEM NO. 232) DISCUSSION: Cases of side effects were reported for personnel taking pyridostigmine tablets. Empirical evidence (i.e.; qualitative clinical experience during the deployment) suggests that side effects did occur but were generally mild and not incapacitating. Some evidence suggests that individuals stopped taking the drug early or a variety of reasons. RECOMMENDATIONS: Question of risks v. benefits of use should be re-addressed by appropriate pharmacology and toxicology experts at the tri-service level employing scientific prospective analysis. ACTIONS REQUIRED: Evaluate risks v. benefits of pyridostigmine tablets , regarding future use. ACTIONS COMPLETED: Noted. Notwithstanding side effects, pyridostigmine tablets will be used in future contingencies where the threat warrants until a more effective substitute is developed. STATUS: Closed.
Document Page: First | Prev | Next | All | Image | This Release | Search